Pulike Biological Engineering

Pulike Biological Engineering EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Pulike Biological Engineering (603566.SS) as of Oct 19, 2026 is 16.73. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 27.23 — a change of -38.55% (lower).

EV/FCF

16.73

YoY

-38.55%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Pulike Biological Engineering is 2025 16.73 . EV/FCF (Enterprise Value to Free Cash Flow) of Pulike Biological Engineering was 2024 27.23 . It decreases by -38.55% lower compared to the previous year.

The Pulike Biological Engineering EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
58.49 CNY
Jan 1, 2019
74.22 CNY
Jan 1, 2020
49.22 CNY
Jan 1, 2021
-42.32 CNY
Jan 1, 2022
-29.01 CNY
Jan 1, 2023
-178.54 CNY
Jan 1, 2024
27.23 CNY
Jan 1, 2025
16.73 CNY
The Pulike Biological Engineering EV/FCF history
YEAREV/FCFYoY
16.73-38.55%
27.23-115.25%
-178.54+515.39%
-29.01-31.45%
-42.32-185.98%
49.22-33.68%
74.22+26.90%
58.49+7.18%
54.57+127.19%
24.02-66.88%
72.52+40.58%
51.58—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulike Biological Engineering Stock analysis

What does Pulike Biological Engineering do? Pulike Biological Engineering Inc, listed on the Shanghai Stock Exchange with ticker 603566.SS and ISIN CNE1000025N0, is a pharmaceutical company based in Luoyang, China. The company went public on May 18, 2015. It employs 1,718 people and operates within the healthcare sector, specifically in the pharmaceuticals industry. Pulike Biological Engineering focuses on the research, development, manufacturing, and sale of biological products for animals, chemical drugs, and Chinese veterinary drugs. The company's veterinary biological products include vaccines and antibodies, which are used for the prevention and control of infectious diseases in poultry and livestock. Its veterinary chemical medicines are primarily used for treating epidemic diseases affecting poultry and livestock. The company is headquartered in Luoyang, Henan, and its website is http://www.pulike.com.cn/. Pulike Biological Engineering Inc is engaged in the research, development, production, and distribution of veterinary biological products and chemical medicines. The firm's product portfolio targets the prevention and treatment of diseases in animals, with a focus on poultry and livestock health management. Pulike Biological Engineering is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulike Biological Engineering stock

EV/FCF (Enterprise Value to Free Cash Flow) of Pulike Biological Engineering is 16.73 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Pulike Biological Engineering changed from 27.23 to 16.73, representing a -38.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Pulike Biological Engineering since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Pulike Biological Engineering with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Pulike Biological Engineering

All Key Metrics — Pulike Biological Engineering